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DNA of 3 unrelated individuals carrying the human plasma butyrylcholinesterase C, variant (CHEZ) was isolated from white blood cells. Southern 
blot patterns of DNA restriction fragments probed with each of the 4 butyrylcholinesterase exons provided evidence that the production of C, 
is not directed by a second butyrylcholinesterase g ne. This finding supports the suggestion that the C, variant is a hybrid enzyme resulting from 
the association of butyrylchohnesterase subunits with a non-choiinesterase protein. 
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1. INTRGDUCTION 
Butyrylcholinesterase (pseudocholinesterase; acyl- 
cho-line acylhydrolase: EC 3.1.1.8) is present in various 
human tissues as well as in plasma and in other 
biological fluids. So far, no physiological function has 
been assigned to this enzyme but it is of phar- 
macological and toxicological importance because it is 
involved in the metabolism of ester containing drugs [I] 
and because it is inhibited by organophosphates and 
carbamates like the related enzyme acetylcholinesterase 
121. 
The plasma BChE shows a complex molecular 
polymorphism. Numerous molecular forms can be 
detected by gel electrophoresis. Four main forms nam- 
ed Cl, CZ, Cp and C4 according to their electrophoretic 
mobility have long been identified [3]. Cl, C3 and C4 
are monomer, dimer and tetramer, respectively [4,5]. 
The Ct component is a BChE monomer-albu~n con- 
jugate [6], Other components are often observed 
depending on storage [3], partial proteolysis [7] and/or 
electrophoresis conditions [8], 
one [9]; this gene has been presumed to direct the pro- 
duction of an additional plasma form called CS because 
it is a slow-migrating component. This form is present 
in 8-10% of Caucasians but is found with lower fre- 
quency in most other populations [l]. Individuals car- 
rying the CS form have an elevated plasma BChE 
activity (up to 30% higher than normal level). The CS 
variant appears to be a hybrid enzyme composed of 
BChE subunits coded by the El gene [9] associated with 
another protein whose nature is still unknown [lo]. 
Other slow-migrating variants have been reported [l]; 
some of them have been observed in malignant diseases 
[ 11,121, but little is known about these forms, and their 
relationship with CS is uncertain. 
Two genetic loci, El and E2 (designated CHEl and 
CHE2 before 1990, and renamed BChE and CHE2 in 
1990 by the Human Gene Nomenclature Com~ttee), 
directing the production of plasma BChE have been 
identified from genetic population studies. The E1 
locus shows a high polyallelism [l]; it encodes for the 
‘normal’ enzyme which exhibits the above-mentioned 
molecular forms. The Ez locus is not allelic to the first 
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Genetic linkage analysis [ 131 and an in situ hybridiza- 
tion study [ 141 assigned the El locus to chromosome 3. 
As regards the E2 locus, linkage studies have shown 
loose linkage between haptoglobin (HP) on 
chromosome 16 and CS (CHE2), Lovrien et al. 1151 
reporting a lod score of 2.347 at a recombination 
distance of 0.25 (males) and 0.32 (females) and 
Marazita et al. [ 171 reporting a lod score of 2.5 1 at a 
recombination distance of 0.32. Lod scores below 3.0 
are considered statistically insignificant and do not 
favor linkage [1.5], In contrast, Eiberg et al. [16] found 
a tight linkage between the y-crystallin gene cluster 
(CRYG) on chromosome 2 and CS (CHE2), reporting 
a highly significant lod score of 4.21 at a recombination 
distance of 0.00. It should be noted that in situ 
hybridization of chromosomes with cloned BChE 
cDNA as probe suggested a homologous site on 
chromosome 16 [14]. This hybridization site might cor- 
respond to the Ez locus. However, the recent deter- 
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Fig. 1. Organization of the BChE gene and position of the exon probes (adapted from Arpagaus et al. [18]). The diagram indicates the organization 
of the human BChE gene and the size of introns. 83% of the coding sequence is in exon 2. The diagram exaggerates the size of exon probes to 
show the presence of flanking intronic sequences. Exon 1 probe is a 0.8 kb PstI/ZfindIII fragment containing 563 bp of 5’ untranslated sequence, 
120 bp of exon 1 and 129 bp of intron 1; exon 2 probe is a 2.4 kb EcoRI/EcoRI fragment containing 1343 bp of exon 2 (exon 2 has 1525 bp 
total) and 1018 bp of intron 2; exon 3 probe is a 1.7 kb EcoRI/XbaI fragment containing 0.7 kb of intron 2, 167 bp of exon 3 and 0.8 kb of 
intron 3; exon 4 probe is a 0.6 kb RsuI/RsaI fragment containing 101 bp of intron 3 and 518 bp of exon 4 (exon 4 has 604 bp total). 
mination of the structure of the BChE gene established 
that BChE is encoded by a single gene corresponding to 
the El locus [18]. 
To investigate the question of the multiplicity of 
BChE genes we decided to probe restriction length 
fragments of genomic DNA from individuals carrying 
the CS variant. For this purpose we prepared 4 32P- 
labeled genomic probes covering the 4 exons of the 
BChE gene and containing adjacent intronic sequences 
(fig.1). Southern blot analysis of hybridized DNA 
fragments indicates unambiguously that the DNA of 
individuals of Cf phenotype contains only one BChE 
gene. 
2. MATERIALS AND METHODS 
2.1. Blood samples 
Blood samples were taken from the Lyon Blood Transfusion 
Center (CRTS de Lyon, 01704 Miribel, France). After venepuncture 
plasma was immediately separated from the blood cells for CS 
phenotyping. Blood bags of 450 ml from donors of phenotype C: 
were collected. Buffy coats were obtained from the blood bags accor- 
ding to the procedure of Cantell et al. [19]. After adding 5 ml of 
dimethylsulfoxide, buffy coat bags were stored at -20°C until DNA 
extraction. 
2.2. CS phenoryping 
CS was phenotyped by unidimensional polyacrylamide gel elec- 
trophoresis using the discontinuous buffer system of Juul [8]. We 
operated in a Hoefer vertical slab gel unit thermostated at 10°C. Gels 
were 1 mm thick and 6% acrylamide gels were used as separating 
gels. 3 ~1 plasma samples were loaded and electrophoreses were run 
for 3 h at constant current (25 mA/plate). After electrophoresis gels 
were stained for cholinesterase activity by the method of Karnovsky 
and Roots [20] with butyrylthiocholine iodide (1 mM) as the 
substrate. 
2.3. DNA extraction from white blood cells 
High molecular weight DNA was isolated from white blood cells 
by the classical phenol-chloroform procedure [21] as modified by 
R.D. Larsen (Howard Hughes Medical Institute, University of 
Michigan; personal communication). 
2.4. Southern blot analyses 
DNA was solubilized in 5 mM Tris-HCl, pH 7.4, containing 
116 
0.1 mM EDTA. DNA samples (-1 fig/PI) were digested with 7 highly 
concentrated restriction endonucleases (EcoRI, HindIII, PvuII, 
TaqI, HindII, XbaI and PstI) purchased from Boehringer Man- 
nheim. 300 units of each enzyme were added to 4Ocg of DNA in 
specific buffers. The digestions were allowed to proceed for 3 h at 
37°C except for TaqI that operated at 65°C. 
Electrophoreses of the restriction fragments (10 rg/lane) were per- 
formed on 1% agarose gel in Hoefer Minnie Horizontal Agarose 
Submarine Units for 90 min at 70 V in 40 rnM Tris/l mM 
NazEDTA-acetate, pH 8.0, containing 0.2 /g/ml of ethidium 
bromide. For each DNA sample, 4 gels for probing the 4 BChE exons 
(fig.1) [18] were run. After electrophoresis the DNA fragments were 
blot transferred onto nylon membranes (GeneScreen, NEN Research 
Products) according to the standard protocol. 
The 4 BChE exon probes were “P-labeled by the random 
oligolabeling method of Feinberg and Vogelstein [22]. Labeling of 
probes was achieved in 6 h at room temperature; lo/r1 of 
[a-“P]dCTP (111 TBq/mmol) from Amersham and 2 units of label- 
ing grade Klenow enzyme (Boehringer Mannheim) were used for each 
labeling (44-105 ng of probe in 100~1 of reaction medium). 
Fig.2. Polyacrylamide gel electrophoresis patterns of human plasma 
cholinesterase. (a) Staining for BChE activity of a plasma sample of 
Cf phenotype. (b) Staining for BChE activity of a plasma sample of 
CS phenotype. (Because the staining process was stopped when the 
major components of BChE Cq and C5 were revealed, the minor 
forms are not perceptible.) 
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Fig.3. Hybridization of genomic blots with four “P-labeled exon probes. DNA was extracted from white blood cells of an individual of phenotype 
Cf. Blot 1 was hybridized with exon 1 probe; 2 with exon 2 probe; 3 with exon 3 probe; 4 with exon 4 probe. 
Prehybridization of membranes was for 6 h at 61°C in 6 x SSC 
buffer (SSC is 0.15 M NaCl/O.OlS M sodium citrate, pH 7.0) con- 
taining 0.25% Carnation instant non-fat milk. Hybridization with 
100 bl of each probe was performed for 20 h at 61°C in 25 ml of 6 x 
SSC/O.25% dry milk (probe concentration: 1.75 ng/ml for exon 1 
probe; 4 ng/ml for the other probes). Then the blots were washed in 
2 x SSC/O.l% sodium dodecylsulfate at 60°C (3 times, 1 h each). 
Autoradiographic exposures were for 3 days at 20°C with Kodak X- 
Among a population of 100 regular 
unrelated individuals were found 
blood donors, 6 
to be of Cf 
phenotype (fig.2). In order to eliminate false positives, 
phenotyping was repeated several times over a period 
of 6 months. Three donors, named A, B and C, ex- 
hibited a high intensity CS band. Interestingly, the in- 
dividual C suddenly turned as CS and became again Cs’ 
two months later. This confirms previous observations 
of several investigators who noted that expression of CS 
is variable and non-mendelian [16,23]. The individuals 
A, B and C were selected for DNA isolation from their 
white blood cells. 
Omat films. 
3. RESULTS AND DISCUSSION 
Fig.3 are genomic blots of restriction fragments 
hybridized with the 4 32P-labeled BChE exon probes. 
As shown, radioactive bands range in size from 0.7 to 
23 kb. For samples A, B and C, whatever the en- 
donucleases used, the number and the size of these 
fragments are identical to those generated from 
genomic DNA from individuals in which the CS variant 
is not phenotypically expressed [181. These data are in 
agreement with the BChE gene structure as determined 
from restriction map of genomic clones [18]. In addi- 
tion, direct sequencing of DNA after amplification by 
the polymerase chain reaction used for identification of 
BChE allelic variants never showed band heterogeneity 
that could mean the existence of a second BChE gene 
(124,251, La Du et al., submitted). All these results sup- 
port the conclusion that only one BChE gene encodes 
the catalytic BChE subunits of CS as well as other 
BChE forms. 
Following the example of the human plasma CZ com- 
ponent [6], CS has to be considered as a conjugate. The 
non-BChE protein still has to be identified. Work is in 
progress in this direction. So far it is certain that this 
protein is neither a degradation product of BChE nor 
acetylcholinesterase, nor albumin nor a collagenous tail 
fragment (P. Masson, unpublished results). The 
observed linkage between CHE2 and the y-crystallin 
gene cluster [ 161 does not imply that y-crystallin is con- 
jugated with BChE subunits to form C5; but this 
hypothesis has still to be tested. We conclude that a se- 
cond gene, previously called Ez, directs the production 
of the non-BChE component of CS and/or the enzymic 
system that controls the assembly of the BChE subunits 
with this protein. 
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